Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 8/2014

01.08.2014 | Rhinology

The role of tissue factor pathway inhibitor-2 in malignant transformation of sinonasal inverted papilloma

verfasst von: Huapeng Yu, Quan Liu, Huan Wang, Dehui Wang, Li Hu, Xicai Sun, Juan Liu

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim was to evaluate the potential role of tissue factor pathway inhibitor-2 (TFPI-2) in the process of malignant transformation of sinonasal inverted papilloma (SIP). We evaluated the expression of TFPI-2 in 23 SIP and 8 SIP with squamous cell carcinoma (IPcSCC), compared to 9 normal sinonasal mucosa by means of Western blot and immunohistochemistry staining. In addition, angiogenesis, vascular endothelial growth factor (VEGF) expression and microvessel density marked by CD105 staining were assessed. Correlation of TFPI-2 expression and angiogenesis in the process of malignant transformation of SIP was investigated. Western blot results demonstrated that the protein level of TFPI-2 in IPcSCC was significantly lower than that in the control group (P < 0.01). In addition, significant difference in TFPI-2 protein expression between SIP and IPcSCC was detected (P < 0.01). Higher number of microvessel per unit area (MVNA) was observed in IPcSCC compared to SIP (P < 0.01). Correlational analysis indicated positive correlation of VEGF and MVNA (r = 0.735), inverse correlation of TFPI-2 and MVNA (r = −0.318). However, no significant correlation between TFPI-2 and VEGF was detected. We conclude that TFPI-2 might be a regulatory molecule in the malignant potential of SIP. Down regulation of TFPI-2 is associated with increased MVNA in IPcSCC, which may be involved in the process of malignant transformation of SIP.
Literatur
1.
Zurück zum Zitat von Buchwald C, Bradley PJ (2007) Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 15:95–98CrossRef von Buchwald C, Bradley PJ (2007) Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 15:95–98CrossRef
2.
Zurück zum Zitat Liu W, Li Z, Luo Q et al (2011) The elevated expression of osteopontin and vascular endothelial growth factor in sinonasal inverted papilloma and its relationship with clinical severity. Am J Rhinol Allergy 25:313–317PubMedCrossRef Liu W, Li Z, Luo Q et al (2011) The elevated expression of osteopontin and vascular endothelial growth factor in sinonasal inverted papilloma and its relationship with clinical severity. Am J Rhinol Allergy 25:313–317PubMedCrossRef
3.
Zurück zum Zitat Ivanciu L, Gerard RD, Tang H et al (2007) Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol 27:310–316PubMedCrossRef Ivanciu L, Gerard RD, Tang H et al (2007) Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol 27:310–316PubMedCrossRef
4.
Zurück zum Zitat Holroyd EW, Delacroix S, Larsen K et al (2012) Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arterioscler Thromb Vasc Biol 32:704–711PubMedCentralPubMedCrossRef Holroyd EW, Delacroix S, Larsen K et al (2012) Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arterioscler Thromb Vasc Biol 32:704–711PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Zhang Q, Zhang Y, Wang SZ et al (2012) Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer. J Exp Clin Cancer Res 31:1PubMedCentralPubMedCrossRef Zhang Q, Zhang Y, Wang SZ et al (2012) Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer. J Exp Clin Cancer Res 31:1PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Edel MJ, Robbins PD, Papadimitriou JM et al (1998) Assessment of vascularity in breast carcinoma by computer-assisted video analysis (CAVA) and its association with axillary lymph node status. Breast Cancer Res Treat 47:17–27PubMedCrossRef Edel MJ, Robbins PD, Papadimitriou JM et al (1998) Assessment of vascularity in breast carcinoma by computer-assisted video analysis (CAVA) and its association with axillary lymph node status. Breast Cancer Res Treat 47:17–27PubMedCrossRef
7.
Zurück zum Zitat Hansen S, Grabau DA, Rose C et al (1998) Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 78:1563–1573PubMed Hansen S, Grabau DA, Rose C et al (1998) Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 78:1563–1573PubMed
8.
Zurück zum Zitat Wojtukiewicz MZ, Sierko E, Zimnoch L et al (2003) Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue. Thromb Haemost 90:140–146PubMed Wojtukiewicz MZ, Sierko E, Zimnoch L et al (2003) Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue. Thromb Haemost 90:140–146PubMed
9.
Zurück zum Zitat Wong CM, Ng YL, Lee JM et al (2007) Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 45:1129–1138PubMedCrossRef Wong CM, Ng YL, Lee JM et al (2007) Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 45:1129–1138PubMedCrossRef
10.
Zurück zum Zitat Tadbir AA, Pardis S, Ashkavandi ZJ et al (2012) Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev 13:5155–5159PubMedCrossRef Tadbir AA, Pardis S, Ashkavandi ZJ et al (2012) Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev 13:5155–5159PubMedCrossRef
11.
Zurück zum Zitat Fonsatti E, Altomonte M, Nicotra MR et al (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557–6563PubMedCrossRef Fonsatti E, Altomonte M, Nicotra MR et al (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557–6563PubMedCrossRef
12.
Zurück zum Zitat Bolzoni VA, Barbieri D, Peretti G et al (2013) Angiogenesis and lymphangiogenesis in early-stage laryngeal carcinoma: prognostic implications. Head Neck 35:1132–1137CrossRef Bolzoni VA, Barbieri D, Peretti G et al (2013) Angiogenesis and lymphangiogenesis in early-stage laryngeal carcinoma: prognostic implications. Head Neck 35:1132–1137CrossRef
13.
Zurück zum Zitat Ran Y, Pan J, Hu H et al (2009) A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma. Hum Gene Ther 20:41–49PubMedCrossRef Ran Y, Pan J, Hu H et al (2009) A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma. Hum Gene Ther 20:41–49PubMedCrossRef
Metadaten
Titel
The role of tissue factor pathway inhibitor-2 in malignant transformation of sinonasal inverted papilloma
verfasst von
Huapeng Yu
Quan Liu
Huan Wang
Dehui Wang
Li Hu
Xicai Sun
Juan Liu
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 8/2014
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-013-2840-2

Weitere Artikel der Ausgabe 8/2014

European Archives of Oto-Rhino-Laryngology 8/2014 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.